Increased number of [125I] BH-substance P receptors in schizophrenia

被引:9
作者
Rioux, L
Nissanov, J
Joyce, JN
机构
[1] Univ Penn, Dept Psychiat, Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19104 USA
[3] Drexel Univ, Comp Vis Ctr Vertebrate Brain Mapping, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA USA
[4] Sun Hlth Res Inst, LJ Roberts Ctr, Sun City, AZ USA
关键词
NK1; receptors; striatum; tachykinin;
D O I
10.1016/S0278-5846(98)00084-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1- This study used quantitative receptor autoradiography to evaluate if the hyperdopaminergic state in the striatum of schizophrenics is associated with decreased NK1 receptor density. 2- A significant increase of NK1 sites was detected in caudate and nucleus accumbens of schizophrenic patients as compared to controls. No statistical difference was observed for the putamen. 3- Neuroleptics used in the treatment of schizophrenia may be responsible for the observed increase in NK1 receptors.
引用
收藏
页码:1295 / 1299
页数:5
相关论文
共 17 条
[1]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[2]  
ARNOLD SE, 1995, AM J PSYCHIAT, V152, P731
[3]   STRIATAL TACHYKININ BIOSYNTHESIS - REGULATION OF MESSENGER-RNA AND PEPTIDE LEVELS BY DOPAMINE AGONISTS AND ANTAGONISTS [J].
BANNON, MJ ;
ELLIOTT, PJ ;
BUNNEY, EB .
MOLECULAR BRAIN RESEARCH, 1987, 3 (01) :31-37
[4]  
CLEVENS RA, 1989, BRAIN RES, V486, P398
[5]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[6]   NIGROSTRIATAL DOPAMINE NEURONS ARE REQUIRED TO MAINTAIN BASAL LEVELS OF SUBSTANCE-P IN THE RAT SUBSTANTIA NIGRA [J].
CRUZ, CJ ;
BECKSTEAD, RM .
NEUROSCIENCE, 1989, 30 (02) :331-338
[7]  
DAVIDSON M, 1987, AM J PSYCHIAT, V144, P934
[8]   SUBSTANCE-P RECEPTORS IN THE HUMAN SPINAL-CORD - DECREASE IN AMYOTROPHIC LATERAL SCLEROSIS [J].
DIETL, MM ;
SANCHEZ, M ;
PROBST, A ;
PALACIOS, JM .
BRAIN RESEARCH, 1989, 483 (01) :39-49
[9]  
HAVERSTICK DM, 1989, J PHARMACOL EXP THER, V248, P858
[10]   DECREASE OF SUBSTANCE-P-LIKE IMMUNOREACTIVITY IN THE SUBSTANTIA NIGRA AND PALLIDUM OF PARKINSONIAN BRAINS [J].
MAUBORGNE, A ;
JAVOYAGID, F ;
LEGRAND, JC ;
AGID, Y ;
CESSELIN, F .
BRAIN RESEARCH, 1983, 268 (01) :167-170